GRAL
GRAIL, Inc.
NasdaqGSUSDEQUITY
Healthcare
DELAYED
Strong buy
+64/100
Last price
138.61
▼ 15.47 (10.04%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
154.89
Prev close
154.08
Day high
166.48
Day low
135.80
Volume
2.04M
Market cap
$6.13B
P/E (TTM)
—
52W range
41.50 – 166.48
Day trading desk
Gap from prior close
+0.53%
Prior close 154.08
VWAP
141.49
-2.04% from price
Relative volume
4.33×
Unusually busy
Session range
23.57%
135.80 – 167.81
Position in range
9%
Near session low
ATR (14D)
13.20
9.52% of price
Prior day high
156.49
PDH
Prior day low
140.30
PDL
Bid / ask spread
—
Quote not published
Session volume
3.95M
Avg 911.58K
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
+0.52%
-1.4%
1M
+70.87%
+69.7%
3M
+95.72%
+91.2%
6M
+179.31%
+161.1%
YTD
+60.39%
+46.1%
1Y
+109.44%
+93.0%
3Y
—
-82.3%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on GRAL open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
-167.37K
Net selling
Buy transactions
12
81.88K shares
Sell transactions
7
249.25K shares
Net transactions
+19
Buys less sells
Sell : buy shares
3.0 : 1
Mixed
Insider-held shares
2.23M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Sep 21, 26 | FREIDIN AARON Chief Financial Officer |
SELL | 4.10K | $382.68K | Direct |
| Sep 21, 26 | OFMAN JOSHUA J. Chief Executive Officer |
SELL | 61.45K | $6.01M | Direct |
| Sep 21, 26 | OFMAN JOSHUA J. Chief Executive Officer |
CONVERSION | 26.45K | $370.33K | Direct |
| Aug 27, 26 | FREIDIN AARON Chief Financial Officer |
SELL | 7.90K | $671.58K | Direct |
| Aug 27, 26 | OFMAN JOSHUA J. Chief Executive Officer |
SELL | 5.00K | $425.10K | Direct |
| Jul 15, 26 | MIZELL STEVEN Director |
STOCK | 268 | $19.93K | Direct |
| Jul 15, 26 | CHASE WILLIAM J Director |
STOCK | 276 | $20.52K | Direct |
| Jul 15, 26 | SUMME GREGORY L Director |
STOCK | 427 | $31.75K | Direct |
| Jun 22, 26 | KREVANS SARAH Director |
STOCK | 5.49K | $350.00K | Direct |
| Jun 18, 26 | MIZELL STEVEN Director |
STOCK | 5.49K | $350.00K | Direct |
| Jun 18, 26 | CHASE WILLIAM J Director |
STOCK | 5.49K | $350.00K | Direct |
| Jun 18, 26 | SUMME GREGORY L Director |
STOCK | 5.49K | $350.00K | Direct |
| Jun 4, 26 | PARTRIDGE ANDREW JOHN Officer |
SELL | 1.49K | $91.07K | Direct |
| Jun 3, 26 | OFMAN JOSHUA J. Chief Executive Officer |
STOCK | 31.05K | $1.99M | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
CHASE WILLIAM J |
Director | 42.98K | Stock Award(Grant) |
DING CHUN R |
Beneficial Owner of more than 10% of a Class of Security | — | Sale |
FREIDIN AARON |
Chief Financial Officer | 248.98K | Sale |
ILLUMINA INC |
Beneficial Owner of more than 10% of a Class of Security | 3.50M | Sale |
KREVANS SARAH |
Director | 42.63K | Stock Award(Grant) |
MIZELL STEVEN |
Director | 42.83K | Stock Award(Grant) |
OFMAN JOSHUA J. |
Chief Executive Officer | 362.27K | Sale |
PARTRIDGE ANDREW JOHN |
Officer | 163.74K | Sale |
RAGUSA ROBERT P. |
Chief Executive Officer | 518.58K | Sale |
SUMME GREGORY L |
Director | 45.67K | Stock Award(Grant) |
Fundamentals
Market cap$6.13B
Enterprise value$5.36B
Revenue (TTM)$165.26M
Gross profit$82.15M
EBITDA$-378.49M
Net income$-391.59M
EPS (TTM)$-8.64
Free cash flow$-103.58M
Total cash$861.61M
Total debt$91.31M
Book value / share$56.93
Shares outstanding44.67M
Float34.34M
Short % of float19.48%
Dividend yield0.00%
Beta (5Y)2.84
Valuation & profitability ratios
Trailing P/E—
Forward P/E-16.66
PEG ratio—
Price / sales—
Price / book2.41
EV / revenue32.44
EV / EBITDA-14.17
Gross margin49.71%
Operating margin-332.00%
Profit margin-236.95%
Return on equity-16.12%
Return on assets-12.03%
Debt / equity3.59
Current ratio10.95
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $147.17M | $125.59M | $93.11M | $55.55M | +17.2% |
| Operating revenue | $147.17M | $125.59M | $93.11M | $55.55M | +17.2% |
| Cost of revenue | $209.75M | $203.62M | $188.72M | $172.00M | +3.0% |
| Gross profit | -$62.57M | -$78.02M | -$95.61M | -$116.45M | +19.8% |
| Research & development | $195.79M | $322.38M | $338.75M | $329.58M | -39.3% |
| Selling, general & admin | $275.80M | $367.82M | $362.56M | $296.44M | -25.0% |
| Total operating expense | $471.59M | $690.20M | $701.30M | $626.01M | -31.7% |
| Operating income | -$534.16M | -$768.22M | -$796.92M | -$742.46M | +30.5% |
| Net interest income | $28.65M | $26.73M | $7.95M | $1.74M | +7.2% |
| Pre-tax income | -$534.50M | -$2.16B | -$1.51B | -$5.44B | +75.3% |
| Tax provision | -$126.15M | -$135.36M | -$41.95M | -$42.29M | +6.8% |
| Net income | -$408.35M | -$2.03B | -$1.47B | -$5.40B | +79.9% |
| Net income to common | -$408.35M | -$2.03B | -$1.47B | -$5.40B | +79.9% |
| Basic EPS | -11.11 | -63.54 | -47.21 | -173.89 | +82.5% |
| Diluted EPS | -11.11 | -63.54 | -47.21 | -173.89 | +82.5% |
| EBIT | -$534.16M | -$768.22M | -$796.92M | -$742.46M | +30.5% |
| EBITDA | -$377.82M | -$610.17M | -$638.22M | -$587.70M | +38.1% |
| Basic shares | 36.75M | 31.90M | 31.05M | 31.05M | +15.2% |
| Diluted shares | 36.75M | 31.90M | 31.05M | 31.05M | +15.2% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $249.73M | $214.23M | $97.29M | $241.60M | +16.6% |
| Cash & short-term investments | $904.43M | $763.47M | $97.29M | $241.60M | +18.5% |
| Accounts receivable | $18.30M | $20.31M | $16.94M | $15.35M | -9.9% |
| Inventory | $16.02M | $18.63M | $21.70M | $19.75M | -14.0% |
| Total current assets | $953.85M | $819.86M | $156.06M | $295.63M | +16.3% |
| Property, plant & equipment | $103.88M | $135.43M | $169.38M | $198.72M | -23.3% |
| Goodwill & intangibles | $1.85B | $2.02B | $3.58B | $4.43B | -8.2% |
| Total assets | $2.92B | $2.98B | $3.91B | $4.94B | -2.1% |
| Total current liabilities | $79.67M | $76.92M | $163.61M | $134.94M | +3.6% |
| Total debt | $54.86M | $68.14M | $84.41M | $96.01M | -19.5% |
| Total liabilities | $344.15M | $479.90M | $267.63M | $291.82M | -28.3% |
| Retained earnings | -$10.21B | -$9.80B | -$7.78B | -$6.31B | -4.2% |
| Shareholder equity | $2.58B | $2.50B | $0 | $0 | +3.0% |
| Working capital | $874.18M | $742.94M | -$7.54M | $160.69M | +17.7% |
| Net tangible assets | $727.31M | $486.51M | -$3.58B | -$4.43B | +49.5% |
| Shares issued | 40.33M | 33.89M | 31.10M | 31.10M | +19.0% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | -$408.35M | -$2.03B | -$1.47B | -$5.40B | +79.9% |
| Depreciation & amortisation | $156.34M | $158.06M | $158.70M | $154.76M | -1.1% |
| Stock-based compensation | $58.28M | $86.08M | $97.23M | $75.73M | -32.3% |
| Change in working capital | $12.41M | -$24.28M | $7.72M | -$14.46M | +151.1% |
| Operating cash flow | -$299.01M | -$577.16M | -$595.80M | -$561.31M | +48.2% |
| Capital expenditure | -$909.00K | -$5.21M | -$12.89M | -$22.86M | +82.5% |
| Investing cash flow | -$85.05M | -$551.01M | -$12.89M | -$22.86M | +84.6% |
| Financing cash flow | $423.32M | $1.24B | $463.77M | $604.82M | -66.0% |
| Free cash flow | -$299.92M | -$582.36M | -$608.69M | -$584.17M | +48.5% |
| End cash position | $256.70M | $217.58M | $101.51M | $246.13M | +18.0% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $44.69M | $40.78M | $43.60M | $36.19M | $35.54M | +9.6% |
| Operating revenue | $44.69M | $40.78M | $43.60M | $36.19M | $35.54M | +9.6% |
| Cost of revenue | $57.25M | $55.09M | $54.73M | $49.93M | $53.32M | +3.9% |
| Gross profit | -$12.57M | -$14.31M | -$11.14M | -$13.73M | -$17.77M | +12.2% |
| Research & development | $47.43M | $48.02M | $46.90M | $48.65M | $46.63M | -1.2% |
| Selling, general & admin | $88.36M | $73.44M | $66.38M | $62.91M | $66.45M | +20.3% |
| Total operating expense | $135.79M | $121.46M | $113.28M | $111.56M | $113.08M | +11.8% |
| Operating income | -$148.36M | -$135.76M | -$124.41M | -$125.29M | -$130.85M | -9.3% |
| Net interest income | $7.23M | $7.99M | $7.96M | $6.11M | $6.81M | -9.5% |
| Pre-tax income | -$166.71M | -$127.52M | -$116.52M | -$118.72M | -$152.86M | -30.7% |
| Tax provision | -$56.46M | -$34.34M | -$17.34M | -$29.74M | -$38.87M | -64.4% |
| Net income | -$110.25M | -$93.19M | -$99.18M | -$88.98M | -$113.98M | -18.3% |
| Net income to common | -$110.25M | -$93.19M | -$99.18M | -$88.98M | -$113.98M | -18.3% |
| Basic EPS | -2.56 | -2.29 | -2.44 | -2.46 | -3.18 | -11.8% |
| Diluted EPS | -2.56 | -2.29 | -2.44 | -2.46 | -3.18 | -11.8% |
| EBIT | -$148.36M | -$135.76M | -$124.41M | -$125.29M | -$130.85M | -9.3% |
| EBITDA | -$109.67M | -$96.97M | -$85.50M | -$86.31M | -$91.68M | -13.1% |
| Basic shares | 43.11M | 40.64M | 40.73M | 36.12M | 35.79M | +6.1% |
| Diluted shares | 43.11M | 40.64M | 40.73M | 36.12M | 35.79M | +6.1% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $55.65M | $69.34M | $249.73M | $126.89M | $127.43M | -19.8% |
| Cash & short-term investments | $861.61M | $823.11M | $904.43M | $540.13M | $602.75M | +4.7% |
| Accounts receivable | $19.76M | $20.34M | $18.30M | $16.28M | $16.31M | -2.9% |
| Inventory | $17.76M | $17.19M | $16.02M | $18.39M | $19.74M | +3.3% |
| Total current assets | $914.72M | $877.35M | $953.85M | $589.38M | $651.84M | +4.3% |
| Property, plant & equipment | $133.25M | $95.91M | $103.88M | $112.24M | $120.24M | +38.9% |
| Goodwill & intangibles | $1.78B | $1.82B | $1.85B | $1.89B | $1.92B | -1.9% |
| Total assets | $2.84B | $2.80B | $2.92B | $2.60B | $2.70B | +1.4% |
| Total current liabilities | $83.54M | $74.71M | $79.67M | $77.43M | $70.64M | +11.8% |
| Total debt | $91.31M | $51.03M | $54.86M | $58.59M | $62.16M | +78.9% |
| Total liabilities | $301.03M | $302.79M | $344.15M | $361.07M | $387.91M | -0.6% |
| Retained earnings | -$10.42B | -$10.30B | -$10.21B | -$10.11B | -$10.02B | -1.1% |
| Shareholder equity | $2.54B | $2.50B | $2.58B | $2.24B | $2.31B | +1.7% |
| Working capital | $831.18M | $802.64M | $874.18M | $511.95M | $581.21M | +3.6% |
| Net tangible assets | $761.26M | $684.71M | $727.31M | $354.82M | $394.92M | +11.2% |
| Shares issued | 44.67M | 41.13M | 40.33M | 36.16M | 36.05M | +8.6% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Net income | -$110.25M | -$93.19M | -$99.18M | -$88.98M | -$113.98M | — | -18.3% |
| Depreciation & amortisation | $38.69M | $38.79M | $38.91M | $38.98M | $39.17M | — | -0.3% |
| Stock-based compensation | $19.56M | $16.79M | $13.77M | $14.14M | $14.17M | — | +16.5% |
| Change in working capital | $8.22M | -$8.14M | $4.88M | $6.76M | -$765.00K | — | +201.1% |
| Operating cash flow | -$80.73M | -$86.99M | -$63.78M | -$63.24M | -$76.97M | — | +7.2% |
| Capital expenditure | -$432.00K | -$503.00K | -$94.00K | -$384.00K | -$369.00K | — | +14.1% |
| Investing cash flow | -$46.58M | -$93.44M | -$236.70M | $66.67M | $70.37M | — | +50.2% |
| Financing cash flow | — | — | $423.32M | $0 | $0 | $0 | — |
| Free cash flow | -$81.16M | -$87.49M | -$63.88M | -$63.63M | -$77.33M | — | +7.2% |
| End cash position | $62.62M | $76.32M | $256.70M | $133.87M | $130.78M | — | -17.9% |
Options analytics
Put / call volume
15.18
Put-heavy session
Put / call open interest
—
Positioning, not flow
Max pain
22.50
-83.6% from spot
ATM implied vol
0.0%
Nearest strike to spot
Skew (10% OTM)
0.0%
Calls bid over puts
Call volume
868
Contracts, this expiry
Put volume
13.18K
Contracts, this expiry
Heaviest call OI
22.50
0 contracts
Heaviest put OI
22.50
0 contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | -2.43 | -1.34 | +44.9% |
| Mar 2026 | -1.96 | -1.37 | +30.1% |
| Dec 2025 | -2.53 | -2.44 | +3.6% |
| Sep 2025 | -3.27 | -2.46 | +24.7% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | -1.90 | 4 | $44.20M | +22.1% |
| Next quarter | -2.09 | 5 | $51.16M | +17.3% |
| Current year | -7.51 | 5 | $180.80M | +22.9% |
| Next year | -8.24 | 4 | $226.62M | +25.3% |
Analyst targets & ownership
Mean target$112.40
High target$175.00
Low target$60.00
Implied upside-18.91%
Analyst count10
ConsensusBUY
Strong buy / Buy0 / 5
Hold6
Sell / Strong sell0 / 0
Held by insiders5.00%
Held by institutions86.29%
Institutions holding501
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
133.71
+3.66% from price
SMA 20
108.61
+26.40% from price
SMA 50
87.97
+56.06% from price
SMA 100
77.14
+79.69% from price
SMA 200
74.28
+84.82% from price
EMA 12
128.10
+8.20% from price
EMA 26
110.51
+25.42% from price
EMA 50
95.94
+44.47% from price
RSI (14)
67.7
Neutral
MACD (12,26,9)
17.59
Hist 3.35
ATR (14)
13.20
9.61% of price
Realised vol 30D
108.2%
Annualised
Bollinger upper
164.27
20, 2σ
Bollinger lower
52.95
20, 2σ
50 / 200 cross
Golden
87.97 vs 74.28
Trend bias
Above 200
+84.82%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
2.79
More volatile than market
Correlation to SPY
0.35
Loosely linked
Realised vol 30D
108.2%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-62.9%
Peak to trough
Max drawdown 5Y
-62.9%
Peak to trough
ATR 14
13.20
9.61% of price
Beta (reported)
2.84
5Y monthly, from filing
Short interest
Shares short
8.57M
Prior 8.16M
Change vs prior
+5.0%
Shorts adding
% of float
19.48%
Elevated
% of shares out
19.18%
Against total outstanding
Days to cover
12.3
Crowded exit
Float
34.34M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 2, 26 | UBS | MAINTAINED | Buy | Buy |
| Oct 1, 26 | Guggenheim | MAINTAINED | Buy | Buy |
| Sep 28, 26 | Canaccord Genuity | MAINTAINED | Buy | Buy |
| Sep 25, 26 | Mizuho | MAINTAINED | Neutral | Neutral |
| Sep 22, 26 | Baird | MAINTAINED | Outperform | Outperform |
| Sep 17, 26 | RBC Capital | INITIATED | — | Sector Perform |
| Sep 9, 26 | UBS | INITIATED | — | Buy |
| Jul 15, 26 | Mizuho | MAINTAINED | Neutral | Neutral |
| Jun 5, 26 | Goldman Sachs | INITIATED | — | Neutral |
| May 6, 26 | TD Cowen | MAINTAINED | Buy | Buy |
| May 6, 26 | Piper Sandler | MAINTAINED | Neutral | Neutral |
| Apr 10, 26 | Mizuho | INITIATED | — | Neutral |
Dividends & splits
Forward rate—
Forward yield0.00%
5-year avg yield—
Payout ratio—
Ex-dividend date—
Next pay date—
Last split—
Split date—
SEC filings
Periodic Financial Reports
10-Q · 2026-08-06
Corporate Changes & Voting Matters
8-K · 2026-08-05
Corporate Changes & Voting Matters
8-K · 2026-06-22
Corporate Changes & Voting Matters
8-K · 2026-06-01
Periodic Financial Reports
10-Q · 2026-05-07
Corporate Changes & Voting Matters
8-K · 2026-05-05
Proxy Statements
DEFA14A · 2026-04-28
Offering Registrations
S-8 · 2026-03-12
Headlines
GRAIL to Present New Data From NHS-Galleri and PATHFINDER 2 at EDCC and ESMO Congress 2026
PR Newswire · 1d ago
Jim Cramer Says This Stock Could Rise Like Moderna (MRNA)
Insider Monkey · 2d ago
Grail Stock Has Skyrocketed 171% in 6 Months. Where Will It Be in 5 Years?
Motley Fool · 3d ago
Why GRAIL (GRAL) Is Up 12.9% After Positive FDA Panel Verdict On Galleri Trial Results
Simply Wall St. · 4d ago
UBS Adjusts GRAIL Price Target to $175 From $105, Maintains Buy Rating
MT Newswires · 5d ago
3 Reasons to Buy Grail (GRAL) Hand Over Fist in October
Motley Fool · 6d ago
Grail Stock Has Soared 180% in 6 Months. Here's Why the Stock Has More Room to Run.
Motley Fool · 7d ago
Why Grail Stock Skyrocketed Nearly 70% In A Week. What To Watch Next.
Investor's Business Daily · 7d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.